OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and thank you for joining OptimizeRx's first quarter fiscal 2026 earnings conference call. With us today is Chief Executive Officer Stephen Silvestro. He is joined by Chief Financial and Strategy Officer Edward Silmak, Chief Legal and Administrative Officer Ariane Odense-Ford, and Chief Business Officer Andrew DeSilva. At the conclusion of today's call, I will provide some important cautions regarding the forward-looking statements made by management during today's call. The company will also be discussing certain non-GAAP financial measures, which it believes are useful in evaluating the company's operating results. A reconciliation of such non-GAAP financial measures is included in the earnings release the company issued this afternoon, as well as in the investment relations section of the company's website. I would like to remind everyone that today's call is being recorded and will be made available for replay as an audio recording of this conference call on the investor relations section of the company's website. Now, I would like to turn the call over to Optimize RMX CEO, Steven Silvestro. Mr. Silvestro, please go ahead. Thank you, Operator, and good afternoon to everyone joining us for today's first quarter 2026 earnings call. We delivered a solid start to the year, which exceeded consensus estimates on the top and bottom line. Revenue for the first quarter was 19.8 million and adjusted EBITDA was 3.3 million. While we're pleased with our performance in the quarter, the broader healthcare technology operating environment continues to evolve. We're seeing ongoing softness in our contracted revenue base relative to prior year levels, largely driven by what appears to be short to intermediate term disruption from last year's most favored...